UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
CBRE Group
CBRE
$43.7B
| $35.9M | 0.03% |
1,048,512
-56,167
| -5% | -$1.8M |
|
|
SCG
502
DELISTED
Scana
SCG
| $35.9M | 0.03% |
593,912
+28,521
| +5% | +$1.58M |
|
|
ATVI
503
DELISTED
Activision Blizzard
ATVI
| $35.8M | 0.03% |
1,778,601
+227,735
| +15% | +$4.6M |
|
504
UDR
UDR
$12.4B
| $35.8M | 0.03% |
1,160,943
-1,217
| -0.1% | -$36.5K |
|
505
Under Armour
UAA
$2.92B
| $35.8M | 0.03% |
1,060,724
-2,965
| -0.3% | -$99.2K |
|
506
Waters Corp
WAT
$38.9B
| $35.7M | 0.03% |
316,742
+17,282
| +6% | +$1.89M |
|
|
TWTR
507
DELISTED
Twitter, Inc.
TWTR
| $35.7M | 0.03% |
994,928
+94,915
| +11% | +$4.04M |
|
508
Travel + Leisure Co
TNL
$4.78B
| $35.7M | 0.03% |
921,668
-34,191
| -4% | -$1.24M |
|
509
Newell Brands
NWL
$2.61B
| $35.5M | 0.03% |
932,106
-18,847
| -2% | -$665K |
|
510
iShares Core S&P 500 ETF
IVV
$900B
| $35.2M | 0.03% |
170,359
+164,259
| +2,693% | +$33.2M |
|
511
AXIS Capital
AXS
$7.57B
| $35.2M | 0.03% |
689,012
+95,228
| +16% | +$4.66M |
|
512
Teva Pharmaceuticals
TEVA
$40.1B
| $35.1M | 0.03% |
610,122
-13,864
| -2% | -$772K |
|
513
Berkshire Hathaway Class A
BRK.A
$1.11T
| $35M | 0.03% |
155
-29
| -16% | -$6.28M |
|
514
American Water Works
AWK
$26.6B
| $35M | 0.03% |
656,882
+30,292
| +5% | +$1.57M |
|
515
Synopsys
SNPS
$77.3B
| $35M | 0.03% |
805,388
+11,768
| +1% | +$489K |
|
516
Celanese
CE
$4.96B
| $34.8M | 0.03% |
579,822
-5,845
| -1% | -$342K |
|
|
AGU
517
DELISTED
Agrium
AGU
| $34.7M | 0.03% |
365,487
-87,423
| -19% | -$8.19M |
|
518
Tractor Supply
TSCO
$17.4B
| $34.6M | 0.03% |
2,193,180
-160
| -0% | -$2.29K |
|
519
Universal Health Services
UHS
$10.2B
| $34.5M | 0.03% |
310,259
+1,945
| +0.6% | +$204K |
|
|
DISCK
520
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $34.4M | 0.03% |
1,019,309
-24,628
| -2% | -$839K |
|
|
SWN
521
DELISTED
Southwestern Energy Company
SWN
| $34.1M | 0.03% |
1,249,300
-1,324
| -0.1% | -$42.5K |
|
522
Eastman Chemical
EMN
$8.45B
| $33.8M | 0.03% |
445,992
-12,395
| -3% | -$980K |
|
523
L3Harris
LHX
$53.1B
| $33.4M | 0.03% |
465,653
-10,382
| -2% | -$718K |
|
|
WX
524
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $33.3M | 0.03% |
989,900
-256,100
| -21% | -$9.05M |
|
525
Ashland
ASH
$3.31B
| $33.3M | 0.03% |
568,794
+3,346
| +0.6% | +$180K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.